Vantage Consulting Group Inc - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 142 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 11.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
Vantage Consulting Group Inc ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$37,000
-14.0%
29,181
+47.7%
0.01%
+11.1%
Q3 2021$43,000
+10.3%
19,751
+89.7%
0.01%
+28.6%
Q2 2021$39,000
+2.6%
10,414
-10.9%
0.01%
-12.5%
Q1 2021$38,000
+137.5%
11,686
+150.5%
0.01%
+700.0%
Q4 2020$16,0004,6660.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,963,756$145,960,0009.42%
Avoro Capital Advisors LLC 3,419,818$71,679,0002.76%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 300,000$6,285,0002.41%
Cormorant Asset Management, LP 1,200,000$25,152,0001.86%
Sio Capital Management, LLC 143,550$3,009,0001.66%
ASHFORD CAPITAL MANAGEMENT INC 425,702$8,923,0001.18%
PURA VIDA INVESTMENTS, LLC 130,700$2,739,0001.10%
Sonora Investment Management, LLC 298,967$6,266,0000.97%
PURA VIDA INVESTMENTS, LLC 100,000$2,096,0000.84%
J. Goldman & Co LP 694,338$14,553,0000.75%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders